2025-02-28 - Analysis Report
## UnitedHealth Group Inc. (UNH) Stock Review

**0) Overview:**

UnitedHealth Group Inc. (UNH) is a diversified healthcare company offering a wide range of health benefits and services.

**1) Performance Comparison:**

UNH's cumulative return (115.08%) significantly outperformed the S&P 500 (VOO) cumulative return (112.87%). The difference is 2.2%, placing it at the 5.4th percentile of the historical range (max: 135.7, min: -5.4) of the spread between UNH and VOO.  This indicates that UNH's outperformance relative to the broader market is not exceptionally high compared to its historical performance.

**Alpha and Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 58.0% | 1.8% | 30.0% | 0.1 | 182.9 |
| 2016-2018  | 66.0% | 10.5% | 47.0% | 0.1 | 209.5 |
| 2017-2019  | 52.0% | 10.5% | 21.0% | 0.3 | 251.4 |
| 2018-2020  | 32.0% | 10.5% | 5.0% | 0.3 | 304.8 |
| 2019-2021  | 96.0% | 9.4% | 26.0% | 0.3 | 442.6 |
| 2020-2022  | 102.0% | 5.5% | 93.0% | 0.3 | 473.3 |
| 2021-2023  | 60.0% | 5.5% | 37.0% | 0.3 | 477.0 |
| 2022-2024  | -24.0% | 16.6% | -57.0% | 0.3 | 465.5 |
| 2023-2025  | -40.0% | 16.6% | -93.0% | 0.2 | 431.2 |

The data shows high CAGR (Compound Annual Growth Rate) in most periods, indicating strong historical growth.  However,  the recent periods (2022-2025) show significant negative CAGR and high MDD (Maximum Drawdown), suggesting increased risk and volatility. Alpha is consistently positive, suggesting outperformance compared to the benchmark, though this seems to be less prominent recently. Beta is relatively low (generally under 1), indicating lower volatility than the market.


**2) Recent Price Movements:**

* Closing Price: $468.56
* 5-day Moving Average: $466.09
* 20-day Moving Average: $513.63
* 60-day Moving Average: $525.14

The price is currently below all three moving averages, suggesting a potential downtrend.


**3) Technical Indicators and Expected Return:**

* RSI: 26.55 (Suggests oversold conditions)
* PPO: -1.33 (Suggests bearish momentum)
* Recent Relative Divergence: -3.7% (Indicates a short-term downward trend)
* Expected Return (2+ years): 1444% (Significant outperformance compared to S&P 500 over the long term is projected. This requires further clarification of assumptions used in calculating this number).
* Price Change: A small increase of $1.07 from the previous close is observed, not signaling a significant upward or downward movement.


**4) Recent Earnings Analysis:**

| Date       | EPS   | Revenue          |
|------------|-------|-------------------|
| 2024-11-04 | 6.56  | $100.82 B        |
| 2024-08-09 | 4.58  | $98.86 B        |
| 2024-05-09 | -1.53 | $99.80 B        |
| 2023-11-06 | 6.31  | $92.36 B        |
| 2024-11-04 | 6.31  | $92.36 B        | *(Duplicate entry - likely an error)*


Revenue remains consistently high, fluctuating around $98B-$100B. EPS shows significant volatility, with a substantial loss in Q2 2024, followed by a strong recovery in Q3 2024.  The duplicate entry needs clarification.


**5) Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue      | Profit Margin |
|---------|--------------|---------------|
| 2024-09-30 | $99.18B     | 21.56%        |
| 2024-06-30 | $97.86B     | 21.52%        |
| 2024-03-31 | $98.78B     | 22.26%        |
| 2023-12-31 | $93.25B     | 22.33%        |
| 2023-09-30 | $91.36B     | 24.51%        |

Revenue is generally stable and growing. Profit margins are relatively consistent, although they show a slight decline in the last two quarters.

**Capital and Profitability:**

| Quarter | Equity       | ROE    |
|---------|--------------|--------|
| 2024-09-30 | $94.53B     | 6.41%  |
| 2024-06-30 | $89.36B     | 4.72%  |
| 2024-03-31 | $86.69B     | -1.63% |
| 2023-12-31 | $88.76B     | 6.15%  |
| 2023-09-30 | $84.49B     | 6.91%  |

Equity is increasing, but ROE (Return on Equity) shows significant fluctuation, including a negative value in Q1 2024, indicating a period of underperformance.


**6) Overall Analysis:**

UNH demonstrates a strong historical growth record, consistently outperforming the S&P 500 over several years, although recent performance has weakened.  The company shows high revenue and generally stable profit margins.  However, recent quarters show increased volatility in earnings and ROE, alongside negative CAGR forecasts for the future. The current price sits below its moving averages, and technical indicators suggest oversold conditions. The projected long-term return is exceptionally high, but needs more context on the calculations.  Further investigation is needed to understand the drivers of the recent volatility and to assess the validity of the projected long-term returns before making any investment decision.  Careful consideration should be given to the risks associated with the observed increased volatility.
